In the news

Through interviews with senior executives and industry analysts, The Boston Globe explores how the combination of Boston Scientific’s acquisition strategy, in-house R&D and investment portfolio position the company for long-term success.

Boston Scientific has completed its $1.18 billion acquisition of Silk Road Medical, adding the TCAR stroke-prevention platform to its vascular portfolio to enhance patient outcomes and expand its minimally invasive treatment options.

Dr. Ken Stein, senior vice president and global chief medical officer, illustrates AI’s potential to enable more personalized care, especially through wearable devices and home-based health monitoring.

Camille Chang Gilmore, vice president of human resources and global chief diversity officer, shares our commitment to developing a workforce that is reflective of the patients and communities we serve, inclusive of individuals with disabilities.

Samir Bhattacharyya, vice president of global value and marketing for Health Economics & Market Access, Urology, discusses the impact erectile dysfunction (ED) can have on work productivity and mental health and the importance of ensuring ED treatment coverage is available to employees.

As the number of people living with conditions like prostate cancer or kidney stones increases, there is also a serious shortage of urologists to meet these growing patient needs. Senior vice president and president of Urology Meghan Scanlon discusses the importance of supporting the next generation of urologists to meet the evolving demands of this field.

Jodi Eddy, senior vice president and chief information and digital officer, shares how she transformed the IT organization and empowered her team to support the company’s strategic priorities.

The Boston Scientific Intracept™ Intraosseous Nerve Ablation System helps transform the lives of people who are living with chronic pain.

In an interview with CNBC’s Jim Cramer, CEO Mike Mahoney shares Boston Scientific’s strong track record of consistently delivering great results and what we’re looking forward to next.

Since 2008, Boston Scientific has worked closely with Boston Health Care for the Homeless Program to help close gaps in medical and social services for those living in shelters or on streets.